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ABSTRACT 
Objectives: To determine to what extent racial and ethnic variation in Medicare spending dur
the last six months of life are explained by demographic, social support, socioeconomic, 
geographic, medical and EOL planning factors.  
Design: Retrospective cohort study 
Setting: Health and Retirement Study (HRS) 
Participants: 7,105 decedents who participated in the Health and Retirement Study between 
1998-2012 and previously consented to survey linkage with Medicare claims. 
Measurements: Total Medicare expenditures in the last 180 days of life by race and ethnicity, 
controlling for demographic factors, social supports, geography, illness burden, and EOL 
planning factors including presence of advance directives, discussion of EOL treatment 
preferences, and whether death  had been expected. 
Results: Our analysis included 5548 (78.1%) non-Hispanic white, 1030 (14.5%) non-Hispanic 
black, 331 (4.7%) Hispanic, and 196 (2.8%) adults of other race/ethnicity. Unadjusted results 
suggest hat average Medicare expenditures for black decedents was $13,522 ( 5%, p <0.001) 
more than for whites, while Medicare expenditures for Hispanics was $16,341 (42%, p<0.001) 
more at EOL. Controlling for demographic, socioeconomic, geographic, medical and EOL 
specific factors, the Medicare expenditure difference between groups reduced to $8,047 (22%, 
p<0.001) more for black and $6,855 (19%, p<0.001) more for Hispanic decedents compared to 
non-Hispanic whites’ expenditures. The expenditure differences between groups remained 
statistically significant across all models. 
Conclusion: Racial and ethnic differences in Medicare spending in the last six months of life are 
not fully explained by patient-level factors, including EOL planning factors. Future resea ch 
should focus on broader systemic, organizational and provider level factors to explain these 
differences. 
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An extensive body of evidence documents racial and ethnic differences in medical care at 
the end-of-life (EOL) (1-14). These include differ nces reported in intensity of care, reported 
patient preferences, and Medicare spending (2, 3, 7, 8, 15). Black decedents have been found to 
spend between 28% and 37% more than white decedents (5, 7, 14, 16-19). 
 Despite examining individual and geographic factors that contribute to overall costs, 
there remains unexplained variation among racial and ethnic groups at EOL. Partial explanatory 
mechanisms include differences in preferences for more expensive, life-prolonging care among 
non-white minorities, with both quantitative and qualitative evidence for such differences (5, 16). 
However, established work suggests that these EOL preferences are not necessarily concordant 
with care received (3).  
We sought to further understand elements that explain the association between race and 
EOL spending by examining a more complete array of patient level factors, including 
demographic, socioeconomic, geographic, medical and EOL planning variables. Guided by a 
modeling framework developed from prior research on mechanisms for racial health disparities 
(Figure 1) (5, 7, 19, 20), we used comprehensive data from the nationally representative Health 
and Retirement Study (HRS) to assess the extent to which racial and ethnic differences in EOL 
spending would be explained by these complex factors. By systematically examining multiple 
patient-level domains that have been associated with disparities in health care, we will better 
understand the causal pathways underlying the expenditure differences across racial and ethnic 
groups at the end of life. We hypothesized that the apparent racial and ethnic differences would 





 We used data from the HRS, a biennial longitudinal survey of a nationally representative 
cohort of U.S. adults aged 51 or older that measures a broad range of scientific questions about 
health and aging (21). The HRS includes sufficient non-white minorities to examine racial and 
ethnic differences among older Americans. Telephone or in-person interviews with HRS 
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participants who have died since the last core interview using information from family members 
and the National Death Index. Exit interviews are conducted with surviving family or friends 
who act as a proxy knowledgeable about the decedent.   
We included HRS decedents aged 65 years or older who died between the 1998 and 2012 
survey waves and who authorized that their HRS responses could be linked to Medicare claims 
data. We only included decedents who were continuously enrolled in Medicare Fee-For-S rvice 
parts A and B in the last six months of life in this analysis (22-24). 
Measures 
The primary outcome was total Medicare expenditures in the last six months of life. This 
measure includes all Medicare claims made for inpatient, outpatient, skilled nursing facility, 
durable medical equipment, home health care, physician supplier, and hospice care. All
expenditures were adjusted for inflation (2012 U.S. dollars) using the medical component of th  
US Bureau of Labor Statistics Consumer Price Index. Our primary analytic interest was in the 
difference between white decedents and either black or Hispanic decedents in the primary 
outcome of interest. 
We included demographic, social support, socioeconomic, geographic, nd medical 
factors that have been shown in previous literature to be associated with Medicare expenditures 
in the last 6 months of life, as well as associated with differences i  costs among racial and 
ethnic groups (Figure 1) (5, 7, 14, 19, 20, 25). Demographic and social support variables 
included self-reported race (non-Hispanic white, non-Hispanic black, Hispanic, other), age at 
death, gender, marital status (married, never ma ried, divorced, widowed, other), residential 
situation (lives at home alone, lives at home with others, lives in nursing home) and birth cohort 
(grouped years of birth by predefined generations from the HRS codebook). We included birth 
cohort as an independent variable in addition to age to control for generational specific 
associations with healthcare knowledge and preferences. 
Socioeconomic variables included educational attainment (<12 years, 12 years, 13-15 
years, ≥ 16 years), net worth by quartile, and non-Medicare insurance coverage (Medicaid, VA 
insurance, or Private insurance/Medigap). Geographic factors were included as urban residency 
determined by ZIP code, and using the End of Life Expenditure Index (EOL-EI) by quintile. 
Using the Dartmouth Atlas of Health Care, we linked each participant to a hospital referral 















This article is protected by copyright. All rights reserved 
physician practice patterns based on utilization patterns among Medicare beneficiaries in the last 
six months of life for each hospital referral region. The EOL-EI takes into account regional 
variation and expenditure patterns that contribute to spending differences at EOL (26, 27). 
We included 30 Elixhauser comorbidities as individual factor variables for each decedent 
to control for illness burden contributing to expenditure differences in the last six months of life 
(28). Using the HRS cognitive functioning measures collected at the decedent’s last survey 
interview, we included cognitive function variables. Cognitive function was categorized as 
normal, mild cognitive impairment, or dementia based on HRS validated definitions (29, 30). We 
also included functional status based on number of deficiencies in Activities of Daily Living 
(ADLs) collected during the last core interview. Functional status was categorized as no 
impairment (no ADL deficiencies), moderate impairment (1-3 ADL deficiencies) or severe 
impairment (4 or more ADL deficiencies).  
End-of-life planning factors include presence of an advance directive, having discussed 
EOL treatment preferences prior to death, nd having an “expected death.” Proxy informants 
were asked in the exit interview “Was the death expected at about the time it occurred or was it 
unexpected?” If the informant answered yes, the death was considered an “expected” death.  
Data Analyses 
We used multivariable generalized linear regression to model the extent to which 
association between race/ethnicity and EOL spending could be accounted for by all known 
factors.  Because of the positively skewed distribution of Medicare expenditure data, the models 
used a gamma distribution with a log link (31). Model coefficients generated by the regression 
models were exponentiated to transform the data into rate ratios (RR). We constructed five 
multivariable models with total Medicare expenditures as the outcome variable, adding 
sequentially the clusters of variables hypothesized to contribute to racial and ethnic differences 
in EOL Medicare expenditures. The clusters were added to the bivariate model (1) with race and 
ethnicity in the following order: (2) demographic and social support variables, (3) socioec nomic 
and geographic indicators, (4) illness burden variables, (5) EOL planning variables. We tested 
for differential effects of all independent variables on total Medicare expenditures by calculating 
the marginal effects by race or ethnicity.  
We imputed covariates for which any data were missing using multiple imputation (5 
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(11%), expecting death (9%), discussed EOL treatment preferences (8%), and having private or 
Medigap insurance (4%).  There were no significant differences in results of multivariable 
analyses using imputed or non-imputed variables. We performed all analyses using STATA13 




 Our study sample included 7,105 Fee-for-Service Medicare beneficiaries aged 65 or older 
who died between the 1998 and 2012 survey waves and whose proxies responded to subsequent 
HRS exit surveys (72% of all Medicare–linked decedents). The characteristics of our study 
population are summarized in Table 1. The respondents included 5548 (78.1%) non-Hispa ic 
whites, 1030 (14.5%) non-Hispanic blacks, 331 (4.7%) Hispanics, and 196 (2.8%) persons of 
other race/ethnicity. Mean total Medicare expenditures across the study population in the last 6 
months of life, adjusted to 2012 U.S. dollars were $41,712 (range $0 to $754,124).  
 Table 2 reports rate ratio (RR) estimates provided by the sequential models to explain 
racial and ethnic differences in EOL expenditures. While controlling for previously hypothesized 
explanatory variables that contribute to differences in racial and ethnic speding at the EOL, the 
final model shows that despite controlling for all of these factors, there was still a significant 
difference in spending for non-Hispanic white, black, and Hispanic decedents. 
The unadjusted results of model (1) show that Medicare expenditures for black decedents 
were 35% more than for whites (RR 1.35, 95% CI 1.26-1.44) and Medicare expenditures for 
Hispanics were 42% more than for whites (RR 1.42, 95% CI 1.27-1.59). Model (2) accounted for 
demographic and social support by including model covariates for gender, age, marital status, 
residential status, and birth cohort. Only age and residential status had a statistically significant 
independent association with EOL Medicare expenditures. Living with others in the decedent’s 
home was associated with increased spending at the EOL (RR 1.08, 95%CI 1.01-1.16), while 
living in a nursing home was associated with decreased EOL Medicare spending (RR 0.83, 95% 
CI 0.77-0.89). Controlling for demographic covariates reduced the difference in expenditures to 
31% (RR 1.31, 95% CI 1.22-1.40) for black decedents compared to whites, while expenditures 
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Model (3) added socioeconomic and geographic indicators to the demographic and social 
support variables of model (2), which further reduced discrepancies in EOL Medicare 
expenditures. Included in this model were educational attainment, net worth (by quartile), urban 
residence, regional End of Life Expenditure Index (EOL-EI) by quintile, and additional 
insurance (Medicaid, VA insurance and private/Medigap were included). Of those, urban 
residence (RR 1.14, 95% CI 1.07-1.20), Medicaid (RR 1.08, 95% CI 1.01-1.16) and 
private/Medigap insurance (RR 1.07, 95% CI 1.01-1. 3) were statistically significantly 
associated with increased EOL expenditures for all races/ethnicities. Each EOL-EI quintile 
contributed an increasing proportion of expenditures. Adjusting for demographic, socioeconomic 
and geographic indicators in this model reduced the difference between both black/white EOL 
expenditures and Hispanic/white expenditures to 25% (RR 1.25, 95% CI 1.16-1.34) and 27% 
(RR 1.27, 95% CI 1.13-1.42), respectively. 
Model (4) considered illness burden in addition to demographic, socioeconomic and 
geographic factors in evaluating expenditures. Factors included in this model were individual 
Elixhauser comorbidities, cognitive function, and functional status based on number of ADL 
limitations. Of the 30 Elixhauser comorbidities included in the model, only 11 of those had a 
statistically significant association with EOL Medicare expenditures (Appendix Table 1).  
Dementia was associated with a statistically significant reduction in EOL Medicare spending 
(RR 0.87, 95% CI 0.81-0.93). Model (4) further decreased the difference in EOL spending for
Finally, model (5) includes EOL planning factors. These variables include presence of an 
advance directive, discussion of EOL treatment preferences, and if death was expected. Having 
an expected death was associated with increased Medicare expenditures in the last six months of 
life. Neither the presence of an advance directive, nor discussion of treatment pref rences for the 
final days of life were significantly associated with average EOL Medicare expenditures. An 
expected death was associated with an increase in EOL expenditures by 24% (RR1.24, 95% CI 
1.18-1.30) compared with those whose death was unexpected. Controlling for demographic, 
socioeconomic, geographic, medical, and end-of-life specific factors in this model shows 
expenditures for black decedents were 22% (RR1.22, 95% CI 1.13-1.31) higher and expenditures 
 
blacks and Hispanics compared to non-Hispanic whites to 20% (RR1.20, 95% CI 1.12-1.29) and 
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for Hispanic decedents were 19% (RR 1.19, 95% CI 1.06-1.33) higher than for non-Hispanic 
whites.  
Figure 2 illustrates the mean differences in EOL expenditures by race for theunadjusted 
model (1) compared to the fully adjusted model (5). In unadjusted analyses, Medicare 
expenditures for black decedents was on average $13,522 more than for non-Hispa ic whites, 
and Medicare expenditures for Hispanic decedents was $16,341 more. Accounting for all 
measured demographic, socioeconomic, geographic, medical, and EOL specific factors, 
Medicare expenditures for black decedents was on average $7,185 more than for non-Hispanic 




In this national sample of decedents, significantly higher Medicare expenditures in non-
Hispanic black and Hispanic decedents were not fully explained by an extensive array of patient 
characteristics. Tested variables included demographic and social supports, socioeconomic 
status, geography, medical, and EOL planning factors. As prior studies examining a more limited 
range of factors found, these variables did explain some of the variation in EOL spending 
between racial and ethnic groups (5, 8, 9, 12, 13, 33, 34). However, even in our fully adjusted 
models, approximately half of the variation remains unaccounted for.  
Differences between racial and ethnic groups in Medicare spending in the last six months 
of life are frequently attributed to differences in patient preferences (2, 3, 5, 14, 33, 35). 
Qualitative survey work supports the conclusion that non-white patients are more likely to prefer 
life-sustaining treatments and more likely to prefer to die in the hospital compared to white 
patients (2, 3, 16, 35-40).  However, inferring that unexplained variation in expenditures is due 
largely to these differences in preferences risks minimizing the extent to which other systemic or 
organizational factors contribute to this expenditure difference. Indeed, questions have been 
raised as to whether patient preferences—by any patient of any race—have any substantial effect 
on EOL care (7, 10, 13, 36, 41). Therefore, our analysis systematically examined several 
mechanisms that might contribute to racial and ethnic differences in EOL Medicare 
expenditures, including some aspects of preferences. Our analysis suggests that EOL expenditure 
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In this way, EOL expenditures are unlike many other health outcomes that have been 
evaluated for the effects of race and ethnicity. Prior studies have demonstrated that often what 
appears to be a race effect on health outcomes can actually be explained by other mechanisms, 
such as socioeconomic status, health literacy, clinical factors, hospital or neighborhood level 
effects, or insurance status (3, 4, 9, 11, 42-45).  While our study included these factors, all of 
which somewhat attenuated the measured association with EOL Medicare expenditures between 
racial and ethnic groups, they failed to explain the total difference. This highlights how 
complexities surrounding care and decision-making at the EOL can be difficult to capture.  
Our results suggest that factors which were not measured in our analysis—or in prior 
analyses—may be important to consider. Following our modeling framework, we were able to 
systematically eliminate several explanatory mechanisms for racial and ethnic variation in EOL 
Medicare expenditures. We suspect it is unlikely that the residual expenditure differentials are 
due solely to remaining patient-level factors, specifically preferences for life-prolonging 
treatment. Rather, we hypothesize that larger system-level or network-based factors are 
contributing to this unexplained difference. Important unexplored mechanisms potentially 
include interactions with the health care system, such as patient-family communication, patient-
provider factors, and provider-provider interactions. As the literature in this area frequently 
focuses on patient level characteristics, insufficient attention has been paid to caregiver, 
provider, or health system contributions to EOL expenditures. Disagreements between family or 
other surrogates and patient preferences are well documented (35), yet little data exists as to how 
family or surrogate characteristics may be associated with EOL expenditures. Additionally, 
providers make assumptions based on presumed EOL preference differences by race, and 
thereby contribute to overall Medicare expenditures by providing unwanted life-sustaining care 
(8, 41, 46, 47).  Further research is needed to understand if including family or caregiver and 
provider-level factors explains more of the variation in EOL expenditures between racial and 
ethnic groups. Much of the work in this domain has included evaluating additional patient level 
variables to understand EOL expenditure differences between racial and ethnic groups. There are 
many stakeholders involved at the EOL, and opportunities exist for these parties to ex rt 
influence in decisions for high cost care. 
Our study has a number of potential limitations. Medicare expenditures do not account 
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by other insurance providers are not captured using these data and likely contribute significantly 
to total overall spending at the EOL. Out-of-Pocket costs for patients and families were also not 
included in this analysis and can be substantial at the EOL (48). Despite adjusting for hospital 
referral regions, facilities may vary within HRRs. We were not able to adjust for physician- or 
facility-level factors that may influence EOL care and utilization (49). The HRS for this time 
period lacks the sample size to study other racial and ethnic groups, therefore our analysis was 
limited to white, black and Hispanic decedents. By identifying decedents and looking 
retrospectively, our data are subject to selection bias because we cannot account for those who 
survived in the same cohort despite a high risk of death. Finally, data from proxy respondents i  
exit interviews were collected retrospectively and could be subject to recall bias. 
Our study finds that both known and previously unexamined mechanisms do not fully 
explain racial and ethnic differences in EOL Medicare expenditures. Having individual 
respondent and proxy data over 14 years of survey collection provided a more detailed 
understanding of specific EOL planning factors that were unable to be examined on a nation l 
level in previous studies (5). However, much of the variation in expenditures remains 
unexplained. We suggest that future research should focus on broader systemic, organizational, 
or social-network factors that might underlie racial and ethnic differences i  EOL spending. Such 
information is essential to developing policies and programs to understand and improve these 
factors that contribute to differences in care and spending at the end of life. 
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Table 1: Decedent Characteristics by Race/Ethnicity 
Characteristic Non-Hispanic 
white 
Black Hispanic Other 
Minority 
     
N (7,105) 5548 1030 331 196 
Age, mean (±SD) 83.0 (±8.47) 81.2 (±9.27) 82.5 (±9.11) 79.5 (±8.71) 
Women, n (%) 3016 (54.4) 592 (57.5) 174 (52.6) 94 (48.0) 
Marital Status, n (%)     
Married 2477 (44.7) 336 (32.7) 143 (43.3) 80 (41.0) 
Never Married 157 (2.83) 45 (4.37) 13 (3.94) 10 (5.13) 
Widowed 2529 (45.6) 515 (50.1) 137 (41.5) 84 (4301) 
Separated/Divorced 384 (6.92) 133 (12.9) 37 (11.2) 21 (10.8) 
Living situation, n (%)     
Lives alone 1497 (27.0) 273 (26.5) 82 (24.8) 50 (25.5) 
Lives with others 2989 (53.9) 560 (54.4) 204 (61.6) 112 (57.1) 
Lives in nursing home 1062 (19.1) 197 (19.1) 45 (13.6) 34 (17.4) 
Educational attainment, n (%)     
<12y 1963 (35.4) 676 (65.6) 260 (78.6) 138 (70.4) 
12y 1901 (34.3) 204 (19.8) 34 (10.3) 26 (13.3) 
13-15y 932 (16.8) 81 (7.86) 23 (6.95) 15 (7.65) 
>16y 750 (13.5) 69 (6.70) 14 (4.23) 17 (8.67) 
Birth year cohort, n (%)     
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CODA (1923-30) 1181 (21.3) 161 (15.6) 59 (17.8) 53 (27.0) 
HRS (1931-41) 1061 (19.1) 307 (29.8) 79 (23.9) 57 (29.1) 
War Baby (1942-47) 47 (0.85) 18 (1.75) 4 (1.21) 6 (3.06) 
Net wealth median in 2012 USD  
(±SD) 








Urban residence, n (%) 2116 (38.2) 508 (49.4) 137 (41.5) 75 (38.5) 
Additional Insurance coverage, n (%)     
Medicaid 823 (15.1) 388 (39.4) 181 (55.9) 85 (44.3) 
Veterans Administration 263 (4.78) 34 (3.38) 7 (2.12) 8 (4.17) 
MediGap (private) 3524 (66.0) 300 (30.4) 59 (18.2) 50 (26.2) 
EOL_EIa   quintile    
1 800 (14.5) 140 (13.7) 14 (4.29) 18 (9.18) 
2 1006 (18.2) 200 (19.6) 6 (1.84) 19 (9.69) 
3 1327 (24.0) 114 (11.2) 39 (12.0) 27 (13.8) 
4 974 (17.6) 203 (19.9) 54 (16.6) 52 (26.5) 
5 1420 (25.7) 362 (35.5) 213 (65.3) 80 (40.8) 
Functional status (# of ADLb   deficiencies)    
independent (0) 2152 (38.9) 338 (33.0) 104 (31.6) 73 (37.8) 
mod impairment (1-3) 1890 (34.2) 335 (32.7) 111 (33.7) 61 (31.6) 
severe impairment (>4) 1489 (26.9) 351 (34.3) 114 (34.7) 59 (30.6) 
Chronic medical conditions     
CHF 1666 (30.0) c 310 (30.1) 105 (31.7) 63 (32.1) 
Chronic pulmonary disease 1565 (28.2) 243 (23.6) 106 (32.0) 66 (33.7) 
Hypertension (complicated + 
uncomplicated) 
3594 (50.6) 898 (12.6) 273 (3.84) 136 (1.91) 
Diabetes (complicated + 
uncomplicated) 
1761 (24.8) 517 (7.28) 206 (2.90) 99 (1.39) 
Renal Failure 662 (11.9) 208 (20.2) 62 (18.7) 33 (16.8) 
Liver disease 150 (2.7) 30 (2.91) 15 (4.53) 11 (5.61) 
Lymphoma 114 (2.05) 14 (1.36) 3 (0.91) 2 (1.02) 
Metastatic Cancer 317 (5.71) 58 (5.63) 14 (4.23) 8 (4.08) 
Solid tumor 951 (17.1) 172 (16.7) 45 (13.6) 20 (10.2) 
Depression 729 (13.1) 82 (7.96) 49 (14.8) 23 (11.7) 
≥2 comorbidities (CCIc 3195 (57.6) ) 648 (62.9) 213 (64.4) 124 (63.3) 
Cognitive Function     
Normal 2270 (41.7) 209 (20.9) 80 (24.6) 39 (20.3) 
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Severe cognitive 
impairment/dementia 
1706 (31.4) 496 (49.6) 159 (48.9) 88 (45.8) 
Median days in hospital (IQRe 7 (0-16) ) 11 (0-25) 12 (0-25) 10 (0-20) 
Advanced Directive, n (%) 3468 (71.9) 332 (37.6) 89 (31.2) 74 (42.1) 
Discussed Treatment Preferences     
yes 2937 (58.7) 373 (38.4) 114 (37.5) 95 (48.7) 
no 2016 (40.3) 588 (60.6) 186 (61.2) 95 (48.7) 
unsure  47 (0.94) 10 (1.03) 4 (1.32) 5 (2.56) 
Died in Hospital, n (%) 1605 (29.3) 387 (38.7) 129 (39.9) 72 (36.9) 
Any hospice use in last 6 months, n (%) 2070 (37.3) 258 (25.1) 95 (28.7) 57 (20.1) 
Death expected?     
yes 3150 (62.3) 492 (52.5) 181 (60.1) 99 (53.5) 
no 1897 (37.5) 441 (47.0) 117 (38.9) 84 (45.4) 
unsure 13 (0.26) 5 (0.53) 3 (1.00) 2 (1.08) 
Median time to deathf
 (IQR)  








a EOL-EI: End of Life Expenditure Index 
b Activities of Daily Living 
c Congestive Heart Failure 
d Charlson Comorbidity Index 
e Interquartile Range 
f
 
Number of months between last core interview and death  
Table 2: Models Examining Explanatory Factors Contributing to Racial/Ethnic Differences in 
Medicare Spending in the Last 6 Months of Life 
Rate Ratios (95% CI) 
  Model 1 Model 2a Model 3b Model 4c Model 5d 
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See appendix table 
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normal) 


















Discussed Preferences (ref = no)      
yes     0.98 
(0.92-1.04) 
unsure/don’t know     1.08 
(0.83-1.39) 
Had advance directive (ref=no)   




















Expected death (ref = no)   










      
a Model 1: Unadjusted analysis 
b Model 2: Model 1 + demographic and social support variables (gender, age, marital status, residential 
status, birth cohort) 
c Model 3: Model 2 + socioeconomic and geographic variables (educational attainment, net worth by 
quartile, urban residence, EOL-EI by quintile, additional insurance –Medicaid, VA, private/Medigap) 
d Model 4: Model 3 + illness burden (Elixhauser comorbidities, functional status by deficiencies in 
Activities of Daily Living, cognitive function)  
e Model 5: Model 4 + End-of-life specific factors (discussed EOL treatment preferences, presence of 
advance directive, death was expected) 
f End of Life 
g Veterans Administration 
f
 
 Activities of Daily Living 
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FIGURE LEGENDS:  
 
Figure 1: Modeling Framework for Factors Contributing to Differences in End-of-Life Care. 
 
Figure 2: Predicted Mean Medicare Expenditures in the Last 6 Months of Life by Race/Ethnicity 
Model (1): Unadjusted analysis of race and total Medicare expenditures. 
Model (5): Multivariable analysis including all demographic & social supports, socioeconomic factors, 
geographic factors, illness burden and end-of-life planning variables.  
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